J&J CEO Choice Keeps Consumer Business At Low Priority
This article was originally published in The Rose Sheet
Executive Summary
Alex Gorsky will replace William Weldon as J&J CEO in April. Like his predecessor, who has led during a time of extensive OTC recalls, Gorsky’s experience with J&J comprises management of Rx pharmaceutical and medical device businesses, with no consumer background.
You may also be interested in...
People In Brief
The Estee Lauder Companies adds responsibilities for two executives, while Coty names a new US Prestige president. More people news in brief.
McNeil Recalls Liquid Infants’ Tylenol With Dosing Device Problem
McNeil Consumer Healthcare recalls an Infants’ Tylenol product that returned to market in November, after receiving consumer complaints about a problem with the SimpleMeasure dosing device system. The recall marks a misstep in the J&J subsidiary’s comeback from OTC quality control issues.
J&J Fills Consumer Chief Post, Promotes Likely CEO Candidates
In a slew of appointments, Johnson & Johnson names a successor for Colleen Goggins as worldwide consumer group chairman and positions two senior executives as likely candidates to be the next CEO.